Category Archives: Cancer

Eric Lefkofsky: CEO of Tempus and Known Philanthropist

Eric Lefkofsky is Co-Founder and CEO for Tempus; a company that helps patients in a clinical setting benefit from the treatment of others who came before them. As CEO of Tempus, Eric is helping to deliver personalized cancer care through interactive analytical and machine learning platform, which allows physicians to make real-time, data-driven decisions based on genomic sequencing and molecular analysis. Partnering with The University of Michigan; Tempus, is hoping to provide new solutions to people suffering from pancreatic cancer. Tempus also works to cure breast cancer and also hopes to begin building databases with information that can help people who suffer from all types of cancer eventually.

Before coming to Tempus, Eric Lefkofsky Co Founded Groupon, which connects millions of subscribers, worldwide, with local merchants by offering goods and services, travel, and activities in more than 28 countries. After leaving Groupon for other endeavors, Eric Co-Founded Lightbank, which specializes in making venture capital investments in what he terms “disruptive” technology companies in the U.S.A. Unlike many venture capitalist companies, Lightbank invests in companies all across the United States and not just those mainly found in Silicon Valley.

Eric Lefkofsky, a native of Chicago is a well-known philanthropist and has set up the Lefkofsky Family Foundation, which advances high impact initiatives, programs, and research that improves the quality of human life. For human rights it supports Americans for Responsible Solutions.

The Homestretch, Human Rights Watch, The Jewish United Fund, Medical Missions, for Children, Newtown: A Documentary, Personal PAC, Planned Parenthood, The Representation Project, and the RFK Center. For education it supports AUSL (Academy for Urban School Leadership), After School Matters, Citizen Schools, The Success Project, Teach for America, Young Women’s Leadership Charter School, Young Chicago Authors and more. For arts and culture it supports the Anderson Ranch Arts Center, Art Institute of Chicago, Aspen Art Museum, The Aspen Institute, Chicago Ideas, Museum of Contemporary Art, Museum of Science and Industry, Ravinia Festival, Steppenwolf Theater, and more. Eric and his wife also joined The Giving Pledge, which is is a campaign to encourage the wealthy people of the world to contribute their wealth to philanthropic causes to learn more: http://lefkofskyfoundation.com/ click here.

Dr. Avi Weisfogels Contributions to the Link Between Dentistry and Sleep Disorders

Avi Weisfogel spends some of his time following the New York Rangers hockey team. Their Youth Hockey Camp educates and inspires kids about hockey. They have reached 10,000 children regionally and host a week long camp for players ages 7 to 15. The coaching staff, alumni and hockey professionals assist with the training and read full article.

Dr. Avi Weisfogel is one of the founders as well as the owner of Dental Sleep Masters. He is dedicated to providing assistance to professionals in the oral health care field who want to improve their practices. He also remains active in the industry as a diplomat for the American Academy of Dental Sleep Medicine. For the last 25 years the academy has improved the methods of treatment for snoring, sleep apnea and sleep related disorders. This is an area of specialty for Dr. Weisfogel.

Dr. Avi Weisfogel graduated from the New York University College and earned his DDS. He has almost twenty years of experience in dental care and services. His focus is on where dentistry and sleep medicine intersect. This was why he opened Dental Sleep Masters in New Jersey. He wanted to provide help for dentists interested in assisting their patients who suffer from sleep apnea.

The most common type of sleep apnea is obstructive sleep apnea. This particular disorder causes an individuals breath to repeatedly halt while they are sleeping. This condition is caused by the relaxation of the throat muscles while a person sleeps and the most common symptom is that of snoring. Obstructive sleep apnea can also result in drowsiness during daytime hours. a headache upon waking and insomnia and contact him.

One of the treatments offered for obstructive sleep apnea is a custom fit oral appliance. The appliance looks a lot like an athletic mouth guard and has the ability to provide jaw support during sleep. This helps in keeping the individuals airway open. In most circumstances a person will receive a referral from their sleep specialist to consult with a dentist. The dentist then fits the person with the oral appliance. The FDA has approved more than 100 oral appliances for obstructive sleep apnea and learn more about Avi.

A Review Of Clay Siegall’s Contribution In Advancing Cancer Research

Research in the field of cancer has been around for many years. However, since the past one decade, this activity has become more intense and focused on availing better solutions to the menace of cancer. Treatment methods that are available are not as perfect as one would want but with the few changes that occurred over the years, the chances of success have widened. Experts like Clay Siegall foresee a future where cancer treatment will offer solutions to even the most complex conditions. He joined the industry to research and develop products for cancer treatment more than 20 years ago and through his company, Seattle Genetics, he has developed useful drug pipelines.

As a clinical scientist whose career has allowed experts to join effort to fight the menace of cancer, Clay Siegall has earned a reputation as one of the most important forces in the fight against cancer. Seattle Genetics is behind the development of pipelines like ADCETRIS, which is gaining adoption at a high rate across many nations. In fact this has since its introduction been the biggest revenue earner for the company. Clay Siegall is hopeful the company will offer better solutions and the success of ADC Technology marks an important milestone in the treatment of cancer.

About Clay Siegall

Clay Siegall, who founded Seattle Genetics, and the CEO of the company, is a renowned expert in cancer research, who has led several efforts to develop drugs and technologies meant to allow easier and better ways of treating cancer. Clay Siegall has been supporting research projects through Seattle Genetics and in this pursuit he invited experts and companies to make the program better.

Having recorded success in several releases of products, Clay Siegall is confident Seattle Genetics will continue to deliver unique and highly dependable cancer treatment methods. His career of over 20 years has molded him into a great leader and a professional with great focus on developing solutions to the most complex challenges in health. His company has been classified among leading research organizations that have been making impact and supporting the fight against cancer.

Clay Siegall: A Dedicated Fight Against Cancer

 

Clay Siegall, the Chairman, President, and Chief Executive Officer of Seattle Genetics, wants to see his efforts to develop an effective cancer therapy to be successful as he is passionate about it. He is putting all the efforts including fundraising for the firm to continue its research in cancer treatment, as he is hopeful that his hard work would save the lives of millions of cancer patients. Since he co-founded the firm almost 20 years back, he strives his effort in cancer research to reduce the struggles of the patients.

Siegall has achieved a number of accomplishments during his career and worked for various research institutes like Bristol-Myers Squibb Pharmaceutical Research Institute and National Cancer Institute before starting with Seattle Genetics. Throughout his career, he focused on addressing the struggles of patients and under him Seattle Genetics have developed antibody-drug conjugates (ADCs) that include ADCETRIS® (brentuximab vedotin) that got the approval of FDA in 2011.

He also played an instrumental role in managing a fundraising of $1.2 billion that includes both public as well as private to meet the research requirements of Seattle Genetics. His role in raising the capital showed that he is not only a great scientist but a visionary leader who can take the cancer research on his shoulders to further heights. His enthusiasm and dedication in the field of cancer research made him winning awards including University of Maryland Alumnus of the Year for the topics Computer, Math and Natural Sciences and Pacific Northwest Ernst & Young Entrepreneur for the year 2012. He leads the firm to show its commitment to patients and research by creating an innovation in treatments.

Siegall played a crucial role in Seattle Genetics for entering strategic agreements with Genentech (Roche), GlaxoSmithKline, Pfizer, and AbbVie on its ADC technology. He has written more than 70 scientific articles that are aimed to educate and encourage the scientific world to continue with the cancer research in a fast paced manner. To cancer research world, he inspires them with his knowledge sharing on treatment methods and discoveries. He completed his Ph.D. in Genetics from the George Washington University before starting his career in research. He also did a Bachelor of Science in Zoology from the University of Maryland.